Resources from the same session
353O - Efficacy and safety of ENZ-124 versus innovator cetuximab in combination with platinum-based chemotherapy in patients with recurrent locoregional or metastatic squamous cell carcinoma of the head and neck (SCCHN)
Presenter: Chetan Deshmukh
Session: Proffered Paper session: Head and neck cancer
Resources:
Abstract
Slides
Webcast
354O - A phase Ib/II study of nanatinostat (Nstat) plus valganciclovir (VGCV) in EBV+ solid tumors and with pembrolizumab (PEM) in recurrent/metastatic nasopharyngeal carcinoma (R/M NPC)
Presenter: Alexander Dimitrios Colevas
Session: Proffered Paper session: Head and neck cancer
Resources:
Abstract
Slides
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Proffered Paper session: Head and neck cancer
Resources:
Webcast
355O - Artificial intelligence-powered spatial analysis of tumor microenvironment (TME) in nasopharyngeal carcinoma (NPC) patients treated with immune checkpoint inhibitors (ICI)
Presenter: Bhumsuk Keam
Session: Proffered Paper session: Head and neck cancer
Resources:
Abstract
Slides
Webcast
356O - Construction of an immune-related adverse events prediction model for teripulimab in the treatment of recurrent metastatic nasopharyngeal carcinoma and its analysis with survival prognosis
Presenter: Qiu yan Chen
Session: Proffered Paper session: Head and neck cancer
Resources:
Abstract
Slides
Webcast
Invited Discussant 355O and 356O
Presenter: Muh-Hwa Yang
Session: Proffered Paper session: Head and neck cancer
Resources:
Slides
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Proffered Paper session: Head and neck cancer
Resources:
Webcast